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LRP6, a co-receptor for the morphogen Wnt, aids endocytosis of anthrax complexes. Here we report that Dickkopf1 (DKK1) 
protein, a secreted LRP6 ligand and antagonist, is also a modulator of anthrax toxin sensitivity. shRNA-mediated gene 
silencing or TALEN-mediated gene knockout of DKK1 reduced sensitivity of cells to PA-dependent hybrid toxins. However, 
unlike the solely inhibitory effect on Wnt signaling, the effects of DKK1 overexpression on anthrax toxicity were bidirectional, 
depending on its endogenous expression and cell context. Fluorescence microscopy and biochemical analyses showed that 
DKK1 facilitates internalization of anthrax toxins and their receptors, an event mediated by DKK1-LRP6-Kremen2 complex. 
Monoclonal antibodies against DKK1 provided dose-dependent protection to macrophages from killing by anthrax lethal toxin 
(LT). Our discovery that DKK1 forms ternary structure with LRP6 and Kremen2 in promoting PA-mediated toxin 
internalization provides a paradigm for bacterial exploitation of mechanisms that host cells use to internalize signaling 
proteins. 
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Anthrax is a lethal disease caused by the combined actions 
of three polypeptide toxins secreted by the gram-positive 
bacterium, Bacillus anthracis: protective antigen (PA, 83 kD), 
lethal factor (LF, 90 kD), and edema factor (EF, 89 kD) [1,2]. 
None of these proteins is individually toxic to the host, but 
bipartite complexes consisting of PA and LF or PA and EF, 
which form lethal toxin or edema toxin, respectively, 
initiate events that result in anthrax disease. LF is a 
zinc-dependent metalloproteinase that blocks the ERK, p38 
and Jun N terminus kinase (JNK) pathways [3] by cleaving 
and inactivating mitogen-activated protein kinase kinases 
(MEKs) 14, 6, and 7 [46]. EF is calmodulin-dependent 
adenylate cyclase that causes rapid accumulation of cAMP, 
leading to multiorgan failure [1,7]. Entry of EF and LF into 
mammalian cells requires interaction of these toxic moieties 
with PA, which attaches them to receptor proteins on the 
surface of targeted cells: tumor endothelium marker-8 
(TEM8; anthrax toxin receptor 1 (ANTXR1)), capillary 
morphogenesis protein-2 (CMG2; anthrax toxin receptor 2 
(ANTXR2)), and integrin β1 complexes [810]. CMG2 is  
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the principal ligand for PA in rodents [11]. As LF lethality 
requires dependence of targeted cells on MAPKK [5,12], 
which normally is observed for macrophages but not for 
most other cell types, FP59, a PA-binding fusion protein 
containing LF amino acids 1254 and the catalytic domain 
of Pseudomonas aeruginosa exotoxin A commonly is 
employed to investigate the binding and internalization 
actions of PA [13,14]. For similar reasons, LFnDTA (a 
fusion of the PA binding domain of LF to the enzymic A 
chain of diphtheria toxin) [15] has also been used as a 
surrogate for LF. At least two other host-encoded cell 
proteins, low density lipoprotein receptor like protein 6 
(LRP6), which has been widely studied as a co-receptor for 
the morphogen Wnt [1618], and ARAP3, a GTPase 
implicated in PI3K signaling [19], do not directly bind to 
PA but can promote endocytosis of PA-complexes [1921]. 
DKK1 (Dickkopf-1) is a secreted, high-affinity ligand for 
LRP6 that antagonizes LRP6-mediated Wnt signaling by 
two distinct mechanisms: (i) by interacting with LRP6, 
DKK1 interrupts Wnt-induced binding of LRP6 to Frizzled 
(Fz), another LRP6 ligand implicated in Wnt signaling, 
interfering with signal transduction without affecting LRP6 
internalization or degradation [2224]; and (ii) DKK1 
forms complexes with LRP6 and Kremen1 or Kremen2— 
transmembrane proteins that trigger internalization of LRP6 
and reduce LRP6 availability at cell surface for Wnt 
signaling [25,26]. It has been proposed recently that DKK1 
can also inhibit Wnt signaling by blocking Wnt binding to 
LRP6 [27,28]. Here we report that DKK1 is a modulator of 
PA-mediated anthrax toxin endocytosis, and that anthrax 
toxin hijacks a ternary complex consisting of DKK1, LRP6 
and Kremen2 to assist with its endocytosis, further linking 
the developmentally-important Wnt signaling pathway to 
anthrax toxin internalization. 
1  Materials and methods 
1.1  Expression constructs 
DKK1 genes were obtained through PCR-amplification 
from human or mouse cDNA, and cloned into pIRES-hyg2 
or pEF6MycHisBsd-B-based vectors for expression.    
1.2  Mammalian cell culture, transfection and 
lentivirus infection  
The human prostate cancer cell line M2182 was maintained 
in RPMI 1640 medium (Invitrogen, USA) by using 
supplements as described in [29]. RAW264.7 mouse 
macrophage, HEK293T, HeLa and BHK cell lines were 
cultured in DMEM (Invitrogen, USA) containing 10% FBS. 
DNA transfections were performed with Polyethylenimine 
(PEI)-mediated method [30], FuGene6 (Roche, Switzerland) 
or Lipofectamin 2000 (Invitrogen, USA) according to the 
manufacturer’s recommended protocols. Lentivirus were 
produced by transient transfection of HEK293T cells (PEI- 
mediated methods) by using DNAs along with packaging 
and VSVG envelope constructs as described [31]. Details 
are the same as reported [20]. 
1.3  Preparation of hDKK1-specific shRNAs  
Expression constructs carrying lentiviral shRNAs speci- 
fically targeting on human DKK1 gene were obtained from 
Openbiosystems, Inc. Stable shRNA expression in the 
vector of pLKO.1 was achieved in M2182 cells through 
viral infection followed by puromycin (1 μg mL1) selection. 
Total of five different DKK1-specific shRNAs were used. 
Their clone IDs and targeting sequences are TRCN- 
0000033384 (5′-CGGGAATAAGTACCAGACCAT), TRC- 
N0000033385 (5′-CGGTTCTCAATTCCAACGCTA), TR- 
CN00000333856 (5′-CCTGTCCTGAAAGAAGGTCAA), 
TRCN0000033387 (5′-GCCAGTAATTCTTCTAGGCTT), 
and TRCN0000033388 (5′-CCAGAAGAACCACCTTGT- 
CTT), respectively. 
1.4  Antibodies 
Full-length His-tagged human DKK1 protein was expressed 
and purified from baculovirus cell supernatants, and 
antibodies were raised against the protein using standard 
hybridoma technology. Hybridoma clone supernatants were 
screened by ELISA and Western analysis, and seven 
positive clones were identified for monoclonal selection and 
antibody purification. The monoclonal antibody against PA 
was obtained from Novus Biologicals (NB 600-407) (USA). 
Agarose-conjugated monoclonal antibodies of c-Myc 
(9E10), HA (F-7) were obtained from Santa Cruz Bio- 
technology (USA). Peroxidase-conjugated mouse mono- 
clonal antibody (clone 9E10) against c-Myc (11814150001) 
and peroxidase-conjugated mouse monoclonal antibody 
(clone 12CA5) against HA (11667475001) were ordered 
from Roche (China) Ltd. Mouse anti-tubulin mAb and 
horseradish peroxidase-conjugated secondary antibodies 
were purchased from Santa Cruz Biotechnology (USA). 
1.5  Immunofluorescence microscopy 
Chimeric LF-EGFP protein purification was the same as 
reported [32]. To monitor cell surface binding, cells were 
first treated with PA83 (600 nmol L1) for 12 min at 37°C, 
washed, incubated with LF-EGFP (200 nmol L1) for 2 min 
at 37°C and immediately washed and fixed before examined 
by confocal microscopy. To monitor PA/LF-EGFP internal- 
ization, cells were incubated with PA83 (600 nmol L1) and 
LF-EGFP (200 nmol L1) for 15 min at 37°C, followed by 
confocal microscopy. Immunostaining was performed 
according to a standard protocol [33]. The cover slips were 
mounted onto slides with a mounting medium containing 
DAPI (Vector Laboratories, USA), and the cells were 
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examined by using an LSM 710&NLO confocal microscope 
(Zeiss, Germany). The detailed procedure was the same as 
reported [32]. 
1.6  Cytotoxicity assay 
PA and LF were purchased from List Biological Labor- 
atories, Inc., and FP59 was produced as described 
previously [34]. LFnDTA, a surrogate of LF consisting of 
the N-terminal domain of LF fused to the catalytic subunit 
of diphtheria toxin, was produced by using plasmid pET- 
15b-LFNDTA (Addgene plasmid 11075) [35]. Cytotoxicity 
assays for M2182, HeLa, HEK293T, and BHK were 
performed by seeding the cells in 96-well plates (100 
μL/well) at a concentration of 5×104 cells mL1 one day 
prior to the toxin treatment; the cell concentration used was 
1×105 cells mL1 for RAW264.7 cell line. Various 
concentrations of PA combined with a fixed concentration 
of FP59 (50 ng mL1) or LF (500 ng mL1 for RAW264.7 
line), or LFnDTA (50 ng mL1) was added to wells, and 
cells were incubated at 37°C for 48 or 18 h (for RAW264.7 
line). Cell viability was measured by MTT assay as 
described [20].  
1.7  Western blotting and co-immunoprecipitation  
Western blotting was performed essentially as described by 
Harlow and Lane [33] using 10% or 3%8% gels (NuPAGE 
Novex Tris-Acetate Gels, EA0378BOX, Invitrogen, USA) 
for electrophoresis and standard conditions. The soluble cell 
proteins were quantitated using BCA protein assay kit 
(Pierce Biotechnology, USA). For co-immunoprecipitation 
assays, HEK293T cells, 48 h after transfection, were lysed 
in NP40 buffer containing a protease inhibitor cocktail 
(Complete Mini, Roche China, Ltd.). The lysates were 
centrifuged at 16000×g, and the soluble fraction was 
immunoprecipitated with the desired antibody-conjugated 
agarose beads (Santa Cruz Biotechnology, USA). 
1.8  Biochemical assay of PA binding and interna- 
lization 
Methods were as described [20]. The concentration and its 
incubation time for binding assay were 1 μg mL1 and 1 h, 
respectively. 
1.9  Construction of stable knockout cell lines using 
TALEN technique 
The design and assembly of the two pairs of TALENs 
constructs used for DKK1 gene-knockout were based on our 
own ULtiMATE protocol [36]. More specifically, the two 
targeting sequences for DKK1 loci are 5′-TCCAACGCT- 
ATCAAG-3′ for TALENL and 5′-GCCCCGCAGCGCCGC- 
3′ for TALENR, with a spacer sequence (5′-AACCTGCCC- 
CCACCGCTGG-3′). The identification and verification of 
gene knockout events were based on both sequencing 
analysis of genome PCR fragments of targeting loci and 
functional assay of Wnt signaling using a beta-catenin- 
regulated promoter on the Super8XTOPflash reporter 
plasmid [37].  
2  Results 
2.1  Effect of DKK1 knockdown on PA-mediated 
toxicity 
Earlier work has shown that reduced activity of LRP6 gene 
mediated by either genetic or immunological interference 
leads to a decrease in the cell killing by anthrax toxin and 
also by a surrogate toxin that is dependent on PA for 
endocytosis [20,21]. LRP6 was found to facilitate 
internalization of PA and toxin moieties bound to it in the 
human prostate cancer cell line M2182 and in mouse 
macrophage RAW264.7 cells [20]. As interference with 
LRP6 function decreases toxin lethality, we wished to learn 
whether inhibition of LRP6 function by its biological 
antagonist DKK1 has the converse effect. To elucidate the 
role of DKK1 in PA-mediated toxicity, five TRC lentiviral 
borne shRNAs specifically targeting the human DKK1 gene 
(Open Biosystems, USA) were introduced individually into 
M2182 cells by viral infection. The effects of one such 
shRNA (TRCN0000033384) that corresponds to an mRNA 
sequence (5′-CGGGAAUAAGUACCAGACCAU) of the 
human DKK1 gene are shown in Figure 1 for two randomly 
selected clones, shRNA384-2 and -6. Stable expression of 
the shRNA under control of the hU6 promoter resulted in 
both a decrease in abundance of DKK1 mRNA (Figure 1A) 
in M2182 cells and a decrease in DKK1 protein in the 
culture media (Figure 1B) to 30% and 50% of normal for 
the M2182/shRNA384-6 and M2182/shRNA384-2 clones, 
respectively. Associated with the observed decreased abun- 
dance of DKK1 mRNA and protein, was sharply increased 
expression of a TCF/beta-catenin-mediated reporter gene as 
assayed using a beta-catenin-regulated promoter on the 
Super8XTOPflash reporter plasmid [37] (Figure 1C), 
consistent with the known inhibitory role of DKK1 in Wnt 
signaling [38]. shRNA (TRCN0000033387) that corres- 
ponds to an mRNA sequence (5′-GCCAGUAAUUCUU- 
CUAGGCUU) of the human DKK1 gene had little effect on 
the abundance of DKK1 mRNA (Figure 1A) or DKK1 
protein (Figure 1B), and consequently had no effect on the 
Wnt signaling (Figure 1C). Data for one such clone 
(M2182/shRNA387-5) are included in this and other figures 
as a negative control.  
Lethality mediated by PA+FP59 in M2182 clones 
shNRA384-2 and -6 was assessed by MTT assay [20] using 
a series of PA concentrations and a fixed concentration of 
FP59 (50 ng mL1). Paradoxically, given the observed
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Figure 1 Effect of human DKK1 down-regulation on M2182 to PA/FP59. TRC lentiviral shRNA (TRCN0000033384) specifically targeting on human 
DKK1 gene was introduced into cells through viral infection. Two such clones (shRNA384-2 and -6) from M2182 were assayed for their cytotoxicity and 
associated gene expression level. Lentiviral shRNA (TRCN0000033387) was used as a control. A, Effect of DKK1-specific shRNA on transcript abundance. 
DKK1 transcripts were measured by quantitative RT-PCR and normalized to 18S rRNA. The primers used to amplify a region of hDKK1 mRNA and 18S 
rRNA were (5′-CCGAGGAGAAATTGAGGAAA and 5′-CCGGAGACAAACAGAACCTT) and (5′-TTTGACTCAACACGGGAAAC and 5′-ATCGCT- 
CCACCAACTAAGAAC), respectively. Data are mean±SD, n=3. B, Effect of DKK1-specific shRNA on secreted DKK1 protein abundance. DKK1 protein 
concentration was measured by Assay Designs’ human DKK1 TiterZyme Immunometric Assay (ELA) kit (Assay Design, USA). C, Effect of DKK1 
deficiency on cellular response to Wnt activation in M2182/shRNA384-2 and -6. Wnt3a-stimulated Wnt signaling was assayed in cells carrying 
Super8XTOPflash reporter plasmid and pcDNA3.1-lacZ plasmid for normalization through transient transfection [20]. Data are mean±SD, n=3. D, 
Cytotoxicity assay of M2182/shRNA384-2 and -6 to PA/FP59. Data are mean±SD, n=6; ***, P<0.005. E, Cytotoxicity assay for the effect of exogenous 
expression of mDKK1 in M2182/shRNA384-6 to PA/FP59; mean±SD, n=6; ***, P<0.005. F, Western blot analysis of exogenous expressed mouse DKK1 
in M2182/shRNA384-6 was conducted as described [20]. The cells carrying corresponding cloning vectors were used as control. β-tubulin abundance was 
measured as an internal control
effects of interference with LRP6 activity, we observed that 
an shRNA-induced decrease in DKK1 expression was asso- 
ciated with increased cell survival in the presence of toxin 
(Figure 1D). Reversal of increased cell survival by shRNA 
directed against human DKK1 in M2182 cells was achieved 
by adventitious expression of mouse DKK1 in these cells 
(Figure 1E and F) (clone shRNA384-6), confirming that the 
effect is specifically a consequence of DKK1 deficiency.  
2.2  Effect of DKK1 knockout on PA-mediated toxicity 
To further determine the role of DKK1 in PA-mediated 
toxicity, DKK1 gene knockout clones were obtained in both 
HEK293T and M2182 cells using the TALEN technique 
[36,39], which enables the introduction of double strand 
DNA breaks at specific chromosomal sites. Analysis of the 
sequence of the TALEN-targeted genome region confirmed 
that the selected HEK293T/DKK1 clone contained at 
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least three types of indels (insertions or deletions) that 
caused a frame shift in the coding sequence of DKK1 
(Figure 2A and B). Similarly, the M2182/DKK1/ clone 
was confirmed to have identical 17-nt deletion in DKK1 
alleles that completely disrupted gene expression (Figure 
2C). The loss of DKK1 gene expression in both HEK293T 
and M2182 cells was functionally confirmed by the elevated 
basal or induced level of Wnt signaling in these clones 
(Figure 2D and F). Importantly, the absence of DKK1 
expression in both lines was associated with less sensitivity 
to PA/LFnDTA (Figure 2E and G), and exogenous 
expression of mDKK1, but not of the mock control (cells 
transfected with only the expression vector), restored 
normal toxin sensitivity to the HEK293T/DKK1 clone 
(Figure 2DE). Our gene knockout data confirm that DKK1 
deficiency in HEK293T and M2182 cells results in 
decreased PA-mediated toxin lethality.  
2.3  Bidirectional effect of DKK1 expression on cell 
susceptibility to PA/FP59 or PA/LFnDTA 
Collectively, the above results and those reported previously 
[20,21] indicate that the actions of both LRP6 and its 
antagonist DKK1 are necessary for normal PA-mediated 
toxicity in HEK293T and M2182 cells. To better understand 
the mechanism(s) underlying such conjoint regulation by 
Wnt signaling proteins, we examined the effect of 
adventitious expression of DKK1 on naïve cells on PA- 
mediated toxicity. By introducing a pIRES-hyg2 based 
construct expressing mouse DKK1 into the M2182 cell line 
and selecting a stably transfected pooled population using 
an appropriate antibiotic marker (500 μg mL1 of hygro- 
mycin), we tested the effects of such overexpression on both 
Wnt signaling and PA-mediated toxicity. As seen in Figure 
3A, we found by measuring beta-catenin activity that the 
Wnt signaling pathway is constitutively active in M2182 
cells, consistent with the published effects of DKK1 on Wnt 
signaling mediated through its known antagonism of LRP6 
[25]. Adventitious DKK1 expression in M2182 cells also 
reduced sensitivity to PA+FP59, enabling M2182 cells to 
survive normally lethal toxin concentrations (Figure 3A, 
right), consistent with earlier evidence that down-regulation 
of LRP6 in M2182 cells decreases cytotoxicity of the 
PA+FP59 complex [20,21].  
Unlike the effects of over-expression of DKK1 in M2182 
cells, such overexpression in HEK293T, HeLa and BHK 
revealed an increase, rather than decrease in toxin sensi- 
tivity (Figures 3B, 3C and 4, right), while still showing the 
expected ability of DKK1 to down-regulate either 
constitutive or induced Wnt signaling (Figures 3B, 3C and 4, 
left). Quantitative PCR analysis revealed that basal 
expression of DKK1 transcripts was significantly different 
in the above cell lines (Figure 3D, left). Additionally, this 
analysis showed that the abundance of DKK1 in M2182 
cells was 30× and 2× greater than that in HEK293T and 
HeLa cells, respectively (Figure 3D, right).  
The above findings raised the possibility that differences 
in the level of endogenous expression of DKK1 may 
determine the consequences of adventitious overexpression 
of the gene and that overall DKK1 concentration above or 
below the optimal range diminishes toxicity. To test this 
notion, we adventitiously expressed increasing amounts of 
DKK1 in HEK293T, which natively expresses a low level 
of DKK1 (Figure 3D), by transfecting cells with increasing 
amounts of a DKK1 expressing plasmid (pEF-hDKK1). 
Whereas increasing amounts of adventitious expression of 
DKK1 resulted in incremental inhibition of Wnt signaling 
(Figure 3E), the effects of incremental DKK1 expression on 
PA-dependent toxicity were bidirectional (Figure 3F). 
Similar effects were observed in DKK1 deficient M2182/ 
DKK1/ cells (Figure 3GJ). Control experiments showed 
no effect of DKK1 on cell viability in the absence of toxin 
(Figure 3H). Collectively, our results suggest that the effect 
of DKK1 on cellular susceptibility to PA-mediated toxicity 
is both bidirectional and dependent on cell context.  
Although we showed that DKK1 promoted PA-mediated 
toxicity of the hybrid toxin FP59 or LFnDTA, we wanted to 
confirm this finding for native anthrax toxin. Accordingly, 
we introduced pIRES-hyg2 and pEF6MycHisBsd-B-based 
constructs expressing human or mouse DKK1 into 
RAW264.7 cells, which are killed by PA/LF [40], and 
selected the stably transfected pooled population using 
appropriate antibiotic markers (500 μg mL1 of hygromycin 
for pIRES-Hyg2 clones, and 2 μg mL1 of Blasticidin for 
pEF6MycHisBsd-B clones). We observed that DKK1 
expression from the introduced DKK1-overexpression 
constructs reduced basal Wnt signaling (Figure 5A), as 
expected, and that adventitious DKK1 expression in 
RAW264.7 cells reduced sensitivity to PA/LF, leading to 
cell survival at normally lethal toxin concentrations (Figure 
5B). This result parallels to the observations we had made 
for M2182 cells exposed to PA+FP59. Moreover, exposure 
of the RAW264.7 macrophage cell line to three of seven 
monoclonal antibodies directed against the full-length 
human DKK1 decreased PA/LF toxicity in a dosedep- 
endent manner (Figure 5C). Control experiments showed 
that none of the seven antibodies tested affected cell viab- 
ility per se, even at the highest antibody dosage (20 μg mL1) 
tested.  
2.4  DKK1 deficiency reduces PA internalization in 
M2182 cells 
The known ability of DKK1, which is a secreted protein [41] 
to modulate LRP6 function, and the previously shown 
ability of LRP6 deficiency to reduce toxin internalization in 
M2182 cells [20] suggested that perturbation of the cellular 
DKK1 level may alter internalization of toxin. As shown in 
Figure 6, Western blot analysis of the lysates from M2182 
cells made resistant to toxin by shRNA384-6, but not by an 
anti-DKK1 shRNA (i.e., shRNA387-5) that was found to 
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Figure 2  Effect of TALEN-mediated DKK1 knockout on cell sensitivity of HEK293T and M2182 to PA/LFnDTA. A, Partial sequence of wild-type 
hDKK1 gene in genome containing TALENs binding regions (overlined for TALENL and underlined for TALENR). DKK1-F and DKK1-R are primers used 
to amplify the TALEN-targeting region of hDKK1 loci. B, Sequencing analysis of mutated alleles from eight randomly selected genome PCR clones (in 
pMD19-T vector) isolated from a single DKK1-targeting-TALEN clone (in HEK293T cells). The primers used to amplify the TALENs targeting region for 
sequencing analysis were 5′-CCTTCTGAGATGATGGCTCTGGGCG-3′ (DKK1-F) and 5′-CCAGACGTCCAGGTACCCGCC-3′ (DKK1-R). Compared 
with the wild-type, four clones had 20-nt deletion (∆20), two clones had 11-nt deletion (∆11), and two clones had 10-nt deletion (∆10). The TALENs 
binding sites (underlined) are highlighted. Dashes and tall letters indicate deletions and insertions, respectively. C, Sequencing analysis of mutated alleles 
from 10 randomly selected genome PCR clones (in pMD19-T vector) isolated from a single DKK1-targeting-TALEN clone (in M2182 cells). All 10 clones 
had 17-nt deletion in the TALEN-targeting region as indicated by dashes. D, Effect of DKK1 knockout and exogenous expressed mouse DKK1 on cellular 
response to native Wnt signaling in HEK293T/DKK1 and HEK293T/DKK1/mDKK1 cells. Wnt signaling assay was conducted as described as in Figure 
1. Data are mean±SD, n=3; ***, P<0.005. E, Cytotoxicity assay of HEK293T/DKK1 and HEK293T/DKK1/mDKK1 to PA/LFnDTA. The cells carrying 
corresponding cloning vectors were used as controls. Data are mean±SD, n=6; ***, P<0.005 for HEK293T/DKK1(vs. HEK293T), and ***, P<0.005 for 
HEK293T/DKK1/mDKK1 (vs. HEK293T/DKK1/vector). F, Effect of DKK1 knockout on cellular response to native Wnt signaling in M2182 cells. 
Data are mean±SD, n=3; ***, P<0.005. G, Cytotoxicity assay of M2182/DKK1 to PA/LFnDTA; mean±SD, n=6; ***, P<0.005. 
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Figure 3  Bidirectional effect of adventitious expression of DKK1 on cell sensitivity to PA/LFnDTA. DKK1 genes were cloned into two kinds of 
expression vectors, pIRES-hyg2 and pEF6MycHisBsd-B. AC (left), Effect of DKK1 over-expression on cellular response to Wnt activation in M2182 (A), 
HEK293T (B), and HeLa (C) cells. Wnt1-stimulated Wnt signaling was assayed in cells carrying Super8XTOPflash reporter plasmid and plasmid carrying 
SV40-Renilla luciferase for normalization through transient transfection. Data are mean±SD, n=3; ***, P<0.005. AC (right), Cytotoxicity of PA/FP59 in 
DKK1-overexpressed M2182 (A), HEK293T (B) and HeLa (C) cells. Cells carrying corresponding cloning vectors were used as controls. Cells were seeded 
at a concentration of 5×103 cells/well (96-well plate), and treated with serially diluted PA and fixed concentration of FP59 (50 ng mL1) for two days before 
being assayed by MTT. Data are mean±SD, n=6; ***, P<0.005. D, Level of DKK1 transcript in M2182, HEK293T and HeLa cells was measured by 
RT-PCR and normalized to GAPDH (D, left). The primers used in PCR reactions were (5′-GACCATTGACAACTACCAGCCGTAC-3′ and 
5′-CCTGAGGCACAGTCTGATGACC-3′) for DKK1, and (5′-ACGGATTTGGTCGTATTGGG-3′ and 5′-CGCTCCTGGAAGATGGTGAT-3′) for GAPDH. 
The relative abundance of DKK1 transcript in these cells was quantified using ImageJ (http://rsbweb.nih.gov/ij/) (D, right). E and F, Effect of increasing 
amount of DKK1 on cellular response to native Wnt signaling (E) and cell survivability to PA/LFnDTA (F) in HEK293T cells. HEK293T cells were 
transfected with serially increased amount of pEF-hDKK1 plasmid DNA (0, 1, 2, 3, 4 μg) using Lipofectamine 2000. The corresponding cloning vector pEF 
was used to ensure that the total amount of DNA used in the transfection was equal (4 μg in total). Forty-eight hours post transfection, cells were assessed for 
both the basal level of Wnt signaling (E) and the cell survivability to PA (6.48 ng mL1)/LFnDTA (50 ng mL1) (F). Data are mean±SD, n=3 (E) and 6 (F). 
GJ, Effect of increasing amount of DKK1 on cellular response to native Wnt signaling (G) and cell survivability to PA/LFnDTA in M2182/DKK1cells 
(HJ). M2182/DKK1 cells were transfected with serially increased amount of pEF-mDKK1 plasmid DNA (0, 15.6, 31.2, 62.5, 125, 250, 500, 1000, 1500, 
and 2000 ng) using X-tremeGENE HP transfection reagent. The corresponding cloning vector pEF was used to ensure that the total amount of DNA used in 
the transfection was equal (2000 ng in total). Forty-eight hours post transfection, cells were split into four portions. One was used to test the basal level of 
Wnt signaling (G), and the other three were used to test the cell survivability to LFnDTA (50 ng mL1) plus variable concentration of PA (0, 15 and 30 ng 
mL1) (HJ). Data are mean±SD, n=3 (G) and 6 (HJ). 
476 Qian LL, et al.   Sci China Life Sci   May (2014) Vol.57 No.5 
 
Figure 4  Effect of adventitious expression of DKK1 on cell sensitivity of 
BHK to PA/FP59. A, Effect of DKK1 over-expression on cellular response 
to native Wnt signaling in BHK cells. Data are mean±SD, n=3; **, P<0.01. 
B, Cytotoxicity of PA/FP59 in DKK1-overexpressed BHK cells. Data are 
mean±SD, n=6; ***, P<0.005. 
not significantly reduce DKK1 expression (Figure 1), 
showed no detectable difference on 83 kD PA monomer 
bound to the cell surface (Figure 6A). However, treatment 
of cells with the DKK1-inhibiting shRNA was associated 
with reduction of an SDS-resistant oligomeric form of PA 
that characteristically survives proteolytic treatment when 
cell cultures exposed to toxin complexes at 4°C are shifted 
to 37°C and toxin complexes are internalized (Figure 6B). 
Confocal fluorescence microscopy using chimeric LF- 
EGFP [32] and PA indicated that the LF detected in the 
cytoplasm, but not at the cell surface, was reduced in the 
DKK1-knockdown clone M2182/shRNA384-6 (Figure 6C), 
consistent with our biochemical evidence of decreased PA 
internalization. We conclude that DKK1 affects anthrax 
toxicity by modulating internalization of the cell surface 
complex containing LRP6, PA, and PA receptors rather than 
by altering the binding of the PA to its receptors. 
2.5  DKK1 forms a ternary complex with LRP6 and 
Kremen2 to internalize PA-mediated toxins 
We have previously shown that LRP6 interacts with PA 
receptors (ANTXRs), ANTXR1/TEM8 and ANTXR2/ 
CMG2 [20]. Co-immunoprecipitation (co-IP) experiments 
showed that DKK1 is also a member of the complexes that  
PA forms with both of these ATRs (Figure 7A and B). In 
these experiments, the C-terminal Myc-tagged hDKK1 or 
HA-tagged mDKK1 was harvested from HEK293T cells 
incubated with lysates containing HA-tagged ANTXR1/ 
TEM8 (ANTXR1-HA) or Myc-tagged ANTXR2∆C/CMG- 
2∆C (ANTXR2∆C-Myc, containing only the extracellular 
and transmembrane region of ANTXR2); DKK1 was 
detected in precipitates of ANTXR1-HA (Figure 7A, left), 
and ANTXR1 was observed in precipitates of DKK1- Myc 
(Figure 7A, right). Similarly, we observed ANTXR2∆C in 
precipitates containing DKK1-HA (Figure 7B, left) and 
found DKK1 in precipitates containing ANTXR2∆C-Myc 
(Figure 7B, right). Although we observed no interaction 
between DKK1 and PA, hDKK1-Myc was able to 
precipitate PA through ANTXR1 (Figure 7C). In addition, 
the presence of PA enhanced the interaction between DKK1 
and ANTXR1 (Figure 7C). This finding plus our 
observation in confocal microscopy that red fluorescence- 
labelled DKK1-Myc co-localized with internalized ANTXR2- 
EGFP triggered by PA (1 μg mL1) (Figure 7D), suggested 
that DKK1 is a component of PA-ANTXR1/2-LRP6 
complex. 
The above result, together with our data showing that 
DKK1 and LRP6 interact functionally to facilitate the 
endocytosis of anthrax toxin, led us to hypothesize that the 
previously described ternary complex consisting of DKK1, 
LRP6 and Kremen2 [26] may facilitate endocytosis of the 




Figure 5  Effects of exogenous expression of DKK1 and anti-hDKK1 monoclonal antibodies on killing of RAW264.7 cells by PA/LF. A, Effect of DKK1 
over-expression on cellular response to native Wnt signaling in RAW264.7 cells. Data are mean±SD, n=3; *, P<0.05. B, Cytotoxicity of PA/LF in 
DKK1-overexpressed RAW264.7 cells. Cells carrying corresponding cloning vectors were used as controls. Data are mean±SD, n=6; ***, P<0.005. C, 
Effect of monoclonal antibodies against hDKK1 on the sensitivity of RAW264.7 cells to PA/LF. 5×104 mL1 cells of RAW264.7 were first seeded in 96-well 
plates (100 μL/well) the day prior to the assay. The cells were pre-incubated with serially diluted antibodies (anti-DKK1-31383144) for 1 h, followed by 
the addition of DMEM growth medium containing or lacking a fixed concentration of toxins (PA and LF, each 50 ng mL1). The plates were incubated at 
37°C and with 10% CO2 for 24 h prior to the cell viability assay as described [20]. Data are mean±SD, n=6. 
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Figure 6  Effect of DKK1 deficiency in M2182 cells on PA binding and internalization. A and B, Western blot analysis of bound (A) and internalized (B) 
PA in different cells was conducted following the protocol as described [20]. PA83 is the full-length form of PA (83 kD), and the oligomer represents the 
heptamer of PA63. α-tubulin or β-tubulin abundance was measured as an internal control. C, Immunofluorescence microscopy of PA/LF-EGFP binding and 
internalization in different cells. To monitor cell surface binding (top), cells were first treated with PA83 (600 nmol L1) for 12 min at 37°C, washed, 
incubated with LF-EGFP (200 nmol L1) for 2 min at 37°C and immediately washed and fixed before examined by confocal microscopy. To monitor 
PA/LF-EGFP internalization (bottom), cells were incubated with PA83 (600 nmol L1) and LF-EGFP (200 nmol L1) for 15 min at 37°C and followed by 
confocal microscopy [32]. Scale bar, 10 μm.  
 
Figure 7  Binding of DKK1 to ANTXR1, ANTXR2 and PA. A, HEK293T cells were transfected with hDKK1-Myc, ANTXR1-HA, or both. Cell lysates 
were treated by addition of anti-HA-conjugated agarose beads (left) or anti-c-Myc-conjugated agarose beads (right). The precipitated proteins were then 
subjected to immunoblotting analysis probed with anti-c-Myc antibody conjugated with horseradish peroxidase (HRP) or anti-HA-HRP. B, HEK293T cells 
were transfected with mDKK1-HA, ANTXR2∆C-Myc, or both. Cell lysates were treated by addition of anti-HA-conjugated agarose beads (left) or 
anti-c-Myc-conjugated agarose beads (right). The precipitated proteins were then subjected to immunoblot analysis probed with anti-c-Myc-HRP or 
anti-HA-HRP. C, HEK293T cells were transfected with hDKK1-Myc, ANTXR1-HA, or both. Cell lysates were then incubated with or without PA83 on ice 
for 2 h before being mixed with anti-c-Myc-conjugated agarose beads. The precipitated proteins were then subjected to immunoblotting analysis probed with 
anti-c-Myc-HRP, anti-HA-HRP or anti-PA antibodies. D, Confocal microscopy images showing co-localization of DKK1-Myc (red) and ANTXR2-EGFP 
(green) in the presence of PA (1 μg mol L1). Three randomly selected images were used. Scale bar, 10 m. 
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hypothesis, we over-expressed LRP6, Kremen2, or LRP6 
plus Kremen2 in M2182 cells under two extreme situations: 
one in which over-expression of DKK1 was constitutive, 
M2182/DKK1 (Figure 8A), and the other one in which 
DKK1 was absent, M2182/DKK1(Figure 8B). In the 
DKK1-high-expression background, adventitious expres- 
sion of LRP6 significantly decreased cell sensitivity to 
PA/LFnDTA, and the addition of Kremen2 had little effect. 
However, adventitious expression of LRP6 plus Kremen2 in 
the presence of abundant DKK1 made M2182 much more 
sensitive to the toxin (Figure 8A). In contrast, in the absence 
of DKK1, the adventitious expression of LRP6, Kremen2 or 
the combination of these two showed no effect on cell 
sensitivity to PA/LFnDTA (Figure 8B). 
3  Discussion 
To exert its toxic effects, anthrax toxins must first enter the 
host cell cytoplasm. Three cell surface proteins can serve as 
receptors for PA [810]. Although the binding of PA to 
only one of the receptors is sufficient for toxin entry 
[4345], loss or reduction in any of the receptors decreases 
toxicity [810], suggesting that these cell surface proteins 
can interact functionally or physically. LRP6, initially 
discovered as a co-receptor for Wnt [1618], is a compo- 
nent of complexes containing ANTXR1/TEM8 and/or 
ANTXR2/CMG2 and can promote internalization of 
anthrax toxin complex [20,21]. Our discovery that DKK1, a 
secreted LRP6 ligand and regulator [22,25], also affects 
anthrax toxin internalization provides additional evidence of 
the role of Wnt signaling proteins on anthrax toxicity.  
Although all three ATRs contain VWA/I domains (von 
Willebrand factor type A domains, also called integrin-like 
domains), their sequences share only 40% overall amino 
acid identity and their primary biological roles in 
mammalian cells are highly disparate [9]. By generating 
ANTXR1/TEM8-, ANTXR2/CMG2-null and TEM8/CMG2 
double null mice, Leppla and colleagues recently have 
shown that ANTXR1/TEM8 plays a relatively minor role in 
mediating anthrax toxicity in rodents. ANTXR1/TEM8-null 
mice were as susceptible as wild type mice to lethal toxin, 
edema toxin, or anthrax spore challenge [11].  
DKK1 is a secreted protein that binds to LRP6, as well as 
to Kremen (Kremen1 or Kremen2), another cell surface 
receptor protein, and the ternary structure formed by the 
interaction of these three proteins triggers rapid 
internalization of the complex [26]—inhibiting Wnt 
signaling. The data presented here and previously [20] 
suggest that the anthrax toxin complex hijacks this ternary 
structure to accomplish toxin endocytosis. Increased DKK1 
production in our experiments resulted in increased 
 
 
Figure 8  Effect of the ternary structure of LRP6/DKK1/Kremen2 on cell sensitivity to anthrax toxin. A and B, Effect of exogenous expression of LRP6, 
Kremen2 or LRP6+Kremen2 in DKK1-overexpressed M2182 (A) or DKK1-deficient M2182/DKK1 (B) on the cytotoxicity of PA/LFnDTA. Cells 
carrying corresponding cloning vectors were used as controls. Data are mean±SD, n=6; ***, P<0.005. C, Model of ternary complex of 
LRP6/DKK1/Kremen2 in the endocytosis of anthrax toxin. Individual or any two-protein combination of LRP6, DKK1 and Kremen2 could potentially bind 
to the anthrax toxin complex, but none of them is capable of mediating the endocytosis process. Therefore, overexpression of DKK1, LRP6, or any 
two-protein combination of LRP6, DKK1 and Kremen2 may cause dominant-negative effect, depending on the basal level of these three proteins. Only the 
complete form of the ternary complex is fully functional to internalize PA-ANTXR1/2-LF/EF, and this ternary complex could undergo internalization by 
itself [26]. 
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antagonism of Wnt signaling, as has been reported 
previously. However, the effects of such increased 
production on toxin sensitivity differed among the cell lines 
tested and were shown to be dependent on the extent of 
overproduction in at least two cell types. Similarly, whereas 
increased antagonism of LRP6-mediated Wnt signaling by 
up-regulation of DKK1 increased toxin lethality in HeLa, 
HEK293T and BHK cells, the reverse was true in M2182 
and RAW267.4 macrophages. Collectively, these findings 
indicate that the effects of DKK1 antagonism of LRP6 are 
not congruent with the effects on Wnt signaling—which can 
also be bidirectional for a given DKK1 perturbation.  
It has been reported that propeller domain 3 of LRP6 
plays a dominant role in binding to DKK1 [26,46]. 
However, DKK1 has also been shown to bind to the first 
propeller domain of LRP6, and monoclonal antibody 
targeting on this region completely protected LRP6 from 
DKK1-mediated internalization [47]. Study of crystal 
structure revealed that the C-terminal domain of DKK1 
binds to the top surface of the third propeller domain of 
LRP6, as well as its first propeller domain [48]. LRP6 has 
been shown to interact with both PA receptors, ATRs [20]. 
Similarly, DKK1 was found to be a component of 
complexes of PA with ANTXR1/TEM8 and ANTXR2/ 
MG2. This finding is not surprising given known ability of 
LRP6 to interact with DKK1 [49]. However, whether 
DKK1 interacts with ATRs through LRP6 or conversely, 
whether DKK1 serves as a bridge between LRP6 and PA 
receptors, is not currently known.    
Anthrax toxin triggers endocytosis of its receptors via a 
lipid raft-mediated process [43], and PA treatment was 
found to be able to recruit LRP6 protein from detergent 
soluble fractions to detergent-resistant membrane (DRM), 
mimicking the process of ATRs upon PA addition [21]. 
Interestingly, LRP6 was found present in lipid raft 
microdomains [50], and DKK1 treatment is able to remove 
LRP6 from the lipid raft [51]. Moreover, the entry of 
anthrax toxin proceeds mainly through a clathrin-dependent 
pathway because PA internalization is dependent on the 
actions of dynamin and Eps15 [43]. Intriguingly, 
DKK1-induced internalization of LRP6 is also dependent 
on clathrin, and the knockdown of clathrin was able to 
suppress the DKK1-dependent inhibition of Wnt signaling 
[52]. DKK1 belongs to a protein family that contains four 
members. Among them, both DKK2 and DKK4 can also 
bind to LRP6, although with lower affinity than DKK1, and 
inhibit Wnt signaling [41,53,54]. Whether the DKK2 and 
DKK4 proteins also participate in anthrax toxin endocytosis, 
and whether there are other secreted factors beyond DKK 
family proteins that can affect anthrax toxin uptake is 
unknown.  
Consistent with earlier evidence that LRP6 promotes PA 
uptake [20,21], antagonism of LRP6 function by overex- 
pression of DKK1 reduced toxin sensitivity in M2182 and 
RAW267.4 cells. However, such enhanced antagonism of 
LRP6 function, as measured by a decrease in Wnt signaling, 
sensitized certain cell lines to PA/FP59, including HeLa, 
HEK293T and BHK cells (this report), suggesting that a 
decrease in LRP6 functionality in cells undergoing 
constitutive Wnt signaling did not significantly decrease 
availability of LRP6 for internalization of toxin. While 
providing additional evidence that Wnt signaling pathway 
components have important roles in toxin endocytosis, our 
findings also show that anthrax toxicity is independent of 
Wnt signaling per se.  
The effects of perturbation of DKK1 production and 
consequently on its antagonism of LRP6 function in 
different cell types may reflect possible differences of 
DKK1/LRP6 ratio, which may in turn be influenced by cell 
type-specific differences in the extent of use of LRP6 for 
autocrine Wnt signaling or the production of other proteins 
that affect toxin entry (e.g., ARAP3; Lu et al.). The 
bidirectional effect of DKK1 overproduction observed in 
HEK293T cells and M2182/DKK is reminiscent of the 
role of DKK2 in LRP-mediated signaling, where the LRP6 
ligand can act as either an inhibitor or an activator of the 
Wnt pathway, depending on the cellular context (i.e., the 
presence or absence of Kremen2) [55]. Kremens enhance 
Wnt signaling by maintaining LRP5/6 at the plasma 
membrane in the absence of DKK1, while they inhibit Wnt 
signaling by promoting the endocytosis of LRP5/6 in the 
presence of DKK1 [24].  
Importantly, using TALEN technology, we were able to 
knock out DKK1 gene expression in both HEK293T and 
M2182 cells. The complete loss of function of DKK1 
confirmed its important role in anthrax toxicity. In addition, 
from the results of expressing DKK1, LRP6 or Kremen2, 
either individually or in combination, in high- or low- 
DKK1-expression M2182 cells, we demonstrated that (i) 
Kremen2 significantly increased cell sensitivity in high 
DKK1/LRP6 background; (ii) LRP6 significantly increased 
cell sensitivity in high DKK1/Kremen2 background; (iii) 
overexpression of LRP6 plus DKK1 greatly decreased cell 
sensitivity to PA-mediated toxicity, a dominant-negative 
effect in comparison with the result of overexpression of 
LRP6/DKK1/Kremen2; and, (iv) effects of LRP6 and/or 
Kremen2 on PA-mediated toxicity were dependent on 
DKK1. We therefore propose a working model in which the 
ternary structure, consisting of DKK1-LRP6-Kremen2, 
promotes the internalization of PA-ANTXR1/2-LF/EF to 
exert their toxic effect. It was reported that the association 
of DKK1, LRP6 and Kremen2 triggers rapid internalization 
of this ternary complex [26]. Overexpression of DKK1, 
LRP6, or any two-protein combination of LRP6, DKK1 and 
Kremen2 may cause dominant-negative effect by competing 
the ternary complex to bind to the anthrax toxin complex 
without mediating the endocytosis of the latter (Figure 8C), 
possibly explaining why both up- and down-regulation of 
DKK1 could reduce cell’s sensitivity to the toxin.  
Worthy of special mention is the finding that even the 
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complete loss of DKK1 in TALEN-mediated knockout cells 
did not make cells completely resistant to PA-mediated 
toxicity. Similarly, the effects of decreased LRP6 function 
on anthrax toxicity have been controversial [20,21,56,57], 
and it has been suggested that differences in results obtained 
in different laboratories may reflect variation in the type of 
cells tested [56,57]. We conclude from this finding that 
there are multiple mechanisms for toxin entry, as suggested 
by evidence that at least three cell surface proteins capable 
of interacting with PA have been identified [810]. 
Although a central role of ANTXR2/CMG2, which binds to 
PA more tightly than other receptors [58,59], has been 
shown for anthrax toxin lethality in mice [11], receptor 
expression is known to differ in different cell types 
[8,9,50,59]. Additionally, knockout of ANTXR1/TEM8 in 
HeLa cells abolished susceptibility to PA/LFnDTA, while 
the knockout of ANTXR2/CMG2 in HeLa cells had no 
effect at all [60]. On the contrary, knockout of ANTXR2/ 
CMG2 in HEK293T cells completely abolished suscept- 
ibility to PA/LFnDTA, while the knockout of ANTXR1/ 
TEM8 in HEK293T cells had no effect [60]. Interestingly, a 
recent publication by Leppla and colleagues [61] showed 
that LT and ET induced lethality are different on distinct 
cell types. 
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